[Changes in serum levels of C-reactive protein and the soluble adhesion molecules, sE-selectin and sICAM-1, after transdermal 17-beta estradiol replacement].
OBJECTIVE: Increases in serum concentrations of C-reactive protein (CRP) and soluble adhesion molecules sE-selectin and sICAM-1 are regarded as risk factors of atherosclerosis now. We aimed to analyse an effect of estrogen replacement therapy (ERT) by transdermal 17-beta estrogen on the variables. DESIGN: A clinical study. SETTING: Division of Gynaecology and Obstetrics, Hospital, Jicín and Department of Gynaecology and Obstetrics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. METHODS: Serum concentrations of CRP (by immunoturbidimetry) and sE-selectin and sICAM-1 (both by ELISA test) were examined in 19 women (median age 50.0 years) after hysterectomy with both side adnexectomy before and after 4 months of continuous transdermal substitution by 17-beta estradiol (ERT) in 1.5 mg dose daily. Data were compared by paired t-test or by Wilcoxon test. P = 0.05, or below was taken as significant. RESULTS: Serum concentration of C-reactive protein was decreased in treated women after 4 months of ERT (before ERT 1.82 +/- 2.20 mg/l, after 4 months of ERT 0.28 +/- 0.55 mg/l; p = 0.006) as well as both soluble adhesion molecules: sE-selectin (before ERT 45.13 +/- 17.3 micrograms/l, after 4 months of ERT 31.39 +/- 9.03 micrograms/l; p = 0.027) and sICAM-1 (before ERT 271.84 +/- 62.30 micrograms/l, after 4 months of ERT 242.86 +/- 62.32 micrograms/l; p = 0.026). CONCLUSION: Transdermal substitution with 17-beta estradiol may reduce one of risk factor of atherogenesis in treated women after hysterectomy with both side adnexectomy.